In a 2011 commentary for the American College of Clinical Pharmacy (ACCP), health policy advisor and physician Terry McInnis stressed the need for pharmacist-physician collaboration to improve positive patient outcomes and reduce health costs. In the last paragraph, it appeals to pharmacists interested in monitoring CPAs: according to the PPAC, the certified pharmacist-clinician can register for a personal AED number (Drug Enforcement Administration). His field of activity is mainly general medicine and therapeutics. Currently, they have a normative authority for these three types of disease status: high cholesterol, diabetes and hypertension in specific disease management protocols.  In addition to the overview below, this resource contains links to the CPA toolkit, a CPA overview site, other resources for CPAs and pharmacy services assistance. In July 2015, the National Alliance of State Pharmacy Associations (NASPA) established a working group consisting of the CEOs of the member organizations of the Joint Commission on Pharmaceutical Practices (JCPP), the National Association of Chain Drug Stores and individual states.  The 18-member task force report made recommendations on what state legislators should include in CPA legislation.   The resource helps pharmacists and prescribers navigate the CPA`s network of requirements and adapt a CPA model to best meet their individual clinical, legal and administrative circumstances. Collaborative Practice Agreements (CPAs) create formal practical relationships between pharmacists and prescribers. CPAs can use collaborative care by defining functions that, in addition to the typical pharmacist`s practice, are delegated to the pharmacist by the co-operative prescriber under negotiated terms defined in the agreement. CPAs are a lobbying priority for professional pharmacy organizations.
In January 2012, the American Pharmacists Association (APhA) brought together a consortium of pharmacy, medical and care professionals from 12 countries to discuss the integration of CPAs into daily clinical practice.  The consortium published a white paper entitled “Consortium Recommendations for Advancing Pharmacists” Patients Care Services and Collaborative Practice Agreements and summarized their recommendations.  For pharmacists, I think you have reached one of the few crossroads that will determine the future of your profession.